Investors Shouldn’t Give in to Irrational Fear: Verso Corporation (VRS), Tocagen Inc. (TOCA)

Verso Corporation (NYSE:VRS) recently ticked higher on strong volume. About 0.71 million contracts were traded on 29-Dec-17 compared to daily average volume of 0.52 million shares. The first sale was made at $16.93 but later the stock became weaker, and closed with a gain of 4.65%. It was last traded at $17.57 apiece.

Verso Corporation (VRS): Buy Candidate With 13.83% Upside Potential

Verso Corporation is maintained at an average buy rating by 2 stock analysts, and there are at least 4.95% of shares outstanding that are currently legally short sold. The shares went up by 61.04% in value last month. Year-to-date it jumped 147.46%. Analysts are turning out to be more optimistic than before, with 2 of analysts who cover Verso Corporation (NYSE:VRS) advice adding it to buy candidate list. Wall Street experts also assign a $20 price target on Verso Corporation, pointing towards a 13.83% rally from current levels. The stock is trading for about 3.26% more than its 52-week high.

Verso Corporation Reports 8.15% Sales Growth

Verso Corporation (VRS) remained unsuccessful in beating the consensus-estimated $0.39 as it actually earned $0.12 per share in its last reported financial results. Revenue, on the other hand, scored 8.15% growth from the previous quarter, coming up with $632.69 million.

VRS Adds 10.09% In A Week

This company shares (VRS) so far managed to recover 454.26% since collapsing to its 52-week low. Over a month, it has seen its stock price volatility to stay at 4.93% while shortening the period to a week, volatility was 5.56%. The share price has already crossed its 20 days moving average, floating at a distance of 28.85% and sits 69.9% higher versus its 50 days moving average. When looking at the past five sessions, the stock returned 10.09% gains and is up by 179.71% compared with its 200-day moving average of $6.88. Also, Verso Corporation (VRS) needs to expand a 153.54% increase it experienced over the past twelve months.

Tocagen Inc. (NASDAQ:TOCA) Consensus Call At 2

As regular trading ended, Tocagen Inc. (TOCA) stock brought in a -$0.61 drop to $10.25. The day started at a price of $11.1 but then traded as high as $11.6152 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2. Tocagen Inc. is given 1 buy-equivalent recommendations, 0 sells and 1 holds. The company shares sank -42.91% from their peak of $17.95 and now has a $194.03 million market value of equity.

Tocagen Inc. Could Grow 130.93% More

TOCA’s mean recommendation on Reuter’s scale presents no change from 2 thirty days ago to 2 now, which indicates a hold consensus from the analyst community. They see Tocagen Inc. (TOCA) price hitting a mean target of $23.67 a share, meaning the stock still has potential that could lift the price another 130.93% Also, the recent close suggests the stock is underpriced by 173.17% compared to the most bullish target.

Tocagen Inc. (TOCA) Returns -17.67% This Year

The company had seen its current volume reaching at 0.31 million shares in the last trade. That compares with the recent volume average of 0.23 million. At the close of regular trading, its last week’s stock price volatility was 6.68% which for the month reaches 8.17%. Tocagen Inc. dipped to as low as $10.15 throughout the day and has returned -17.67% in this year. At one point in the past year, the shares traded as low as $8.60 but has recovered 19.19% since then.

Previous articleRunning Out Of Momentum? – Vericel Corporation (VCEL), Agios Pharmaceuticals, Inc. (AGIO)
Next articleWhat Really Matters in the Long Run? – Sequential Brands Group, Inc. (SQBG), Avino Silver & Gold Mines Ltd. (ASM)